We are live on ! Find out more
AEMD icon

Aethlon Medical

13 hedge funds and large institutions have $604K invested in Aethlon Medical in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

38% more capital invested

Capital invested by funds: $437K → $604K (+$167K)

8% more funds holding

Funds holding: 1213 (+1)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q2 2020 in Review

13 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2020, worth a combined $604K — up 38% from $437K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AEMD positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $26.6K. The largest seller was Ancora Advisors, exiting entirely with an estimated $46K sold.

  • 13 institutional investors held Aethlon Medical (AEMD) as of Q2 2020, up from 12 in Q1 2020.
  • Funds reported $604K of Aethlon Medical stock for Q2 2020, up 38% quarter-over-quarter.
  • 3 funds opened new Aethlon Medical positions in Q2 2020 and 2 closed out, a net change of +1 holder.
  • The largest Aethlon Medical buyer in Q2 2020 was Geode Capital Management, an estimated $26.6K added.
  • The largest Aethlon Medical seller in Q2 2020 was Ancora Advisors, an estimated $46K sold.

Based on aggregated 13F filings for Q2 2020.